Growth Metrics

Jaguar Health (JAGX) Depreciation & Amortization (CF) (2016 - 2025)

Jaguar Health (JAGX) has disclosed Depreciation & Amortization (CF) for 10 consecutive years, with $477000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) changed 0.21% to $477000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 0.68% year-over-year, with the annual reading at $1.9 million for FY2025, 0.68% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $477000.0 at Jaguar Health, roughly flat from $479000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $558000.0 in Q2 2022, with the low at $426000.0 in Q1 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $476300.0, with a median of $478500.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) increased 29.77% in 2022, then fell 11.13% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $429000.0 in 2021, then rose by 16.32% to $499000.0 in 2022, then grew by 0.6% to $502000.0 in 2023, then fell by 4.78% to $478000.0 in 2024, then dropped by 0.21% to $477000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $477000.0, $479000.0, and $478000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.